Allakos Inc.

NasdaqGS:ALLK 株式レポート

時価総額:US$91.2m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております!

Allakos マネジメント

マネジメント 基準チェック /34

Allakos'の CEO はRobert Alexanderで、 Apr2017年に任命され、 の在任期間は 7.17年です。 の年間総報酬は$ 6.30Mで、 12.8%給与と87.2%のボーナス(会社の株式とオプションを含む)で構成されています。 は、会社の株式の0.77%を直接所有しており、その価値は$ 799.18K 。経営陣と取締役会の平均在任期間はそれぞれ3.2年と6年です。

主要情報

Robert Alexander

最高経営責任者

US$6.3m

報酬総額

CEO給与比率12.8%
CEO在任期間7.2yrs
CEOの所有権0.8%
経営陣の平均在職期間3.2yrs
取締役会の平均在任期間6yrs

経営陣の近況

Recent updates

We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate

May 05
We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate

We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate

Dec 01
We're Keeping An Eye On Allakos' (NASDAQ:ALLK) Cash Burn Rate

Companies Like Allakos (NASDAQ:ALLK) Are In A Position To Invest In Growth

Aug 03
Companies Like Allakos (NASDAQ:ALLK) Are In A Position To Invest In Growth

Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely

Apr 20
Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely

Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value

Jan 04
Is Allakos Inc. (NASDAQ:ALLK) Expensive For A Reason? A Look At Its Intrinsic Value

Allakos: Potential For Comeback With Lirentelimab With 2 Indications

Oct 18

Allakos prices ~$150M underwritten offering

Sep 19

Allakos falls as lead asset offers mixed results in late-stage trial

Sep 09

Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely

Aug 06
Allakos (NASDAQ:ALLK) Will Have To Spend Its Cash Wisely

Will Allakos (NASDAQ:ALLK) Spend Its Cash Wisely?

Apr 22
Will Allakos (NASDAQ:ALLK) Spend Its Cash Wisely?

Allakos: Sad End To A Promising Asset

Dec 23

We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely

Dec 01
We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely

We Think Allakos (NASDAQ:ALLK) Can Afford To Drive Business Growth

Aug 16
We Think Allakos (NASDAQ:ALLK) Can Afford To Drive Business Growth

Allakos: Upcoming Phase 3 Data Makes The Stock Interesting

Aug 06

Allakos provides lirentelimab clinical trial enrollment updates, names new CMO

Jun 07

We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely

May 02
We're Hopeful That Allakos (NASDAQ:ALLK) Will Use Its Cash Wisely

Have Allakos Inc. (NASDAQ:ALLK) Insiders Been Selling Their Stock?

Mar 10
Have Allakos Inc. (NASDAQ:ALLK) Insiders Been Selling Their Stock?

Allakos Inc. (NASDAQ:ALLK) Insiders Have Been Selling

Jan 28
Allakos Inc. (NASDAQ:ALLK) Insiders Have Been Selling

We're Interested To See How Allakos (NASDAQ:ALLK) Uses Its Cash Hoard To Grow

Dec 07
We're Interested To See How Allakos (NASDAQ:ALLK) Uses Its Cash Hoard To Grow

Allakos EPS misses by $0.02

Nov 09

CEO報酬分析

Allakos の収益と比較して、Robert Alexander の報酬はどのように変化したか?
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$214m

Dec 31 2023US$6mUS$805k

-US$186m

Sep 30 2023n/an/a

-US$166m

Jun 30 2023n/an/a

-US$151m

Mar 31 2023n/an/a

-US$165m

Dec 31 2022US$7mUS$782k

-US$320m

Sep 30 2022n/an/a

-US$371m

Jun 30 2022n/an/a

-US$403m

Mar 31 2022n/an/a

-US$411m

Dec 31 2021US$11mUS$745k

-US$270m

Sep 30 2021n/an/a

-US$220m

Jun 30 2021n/an/a

-US$199m

Mar 31 2021n/an/a

-US$181m

Dec 31 2020US$14mUS$710k

-US$153m

Sep 30 2020n/an/a

-US$134m

Jun 30 2020n/an/a

-US$113m

Mar 31 2020n/an/a

-US$93m

Dec 31 2019US$13mUS$600k

-US$85m

Sep 30 2019n/an/a

-US$75m

Jun 30 2019n/an/a

-US$65m

Mar 31 2019n/an/a

-US$55m

Dec 31 2018US$8mUS$500k

-US$44m

Sep 30 2018n/an/a

-US$37m

Jun 30 2018n/an/a

-US$32m

Mar 31 2018n/an/a

-US$27m

Dec 31 2017US$1mUS$300k

-US$24m

報酬と市場: Robertの 総報酬 ($USD 6.30M ) は、 US市場 ($USD 678.50K ) の同規模の企業の平均を上回っています。

報酬と収益: Robertの報酬は、過去 1 年間の会社の業績と一致しています。


CEO(最高経営責任者

Robert Alexander (54 yo)

7.2yrs

在職期間

US$6,299,426

報酬

Dr. Robert Alexander, Ph D., had been an Independent Director of Allena Pharmaceuticals, Inc. since June 2016 until 2022. He has been the Chief Executive Officer of Allakos Inc. since April 2017 and served...


リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Robert Alexander
CEO & Director7.2yrsUS$6.30m0.77%
$ 703.6k
Adam Tomasi
President4.8yrsUS$4.27m0.32%
$ 294.5k
Baird Radford
Chief Financial Officer3.2yrsUS$2.74mデータなし
Mary Cromwell
Chief Technical Officerless than a yearデータなしデータなし
Chin Lee
Chief Medical Officerless than a yearデータなしデータなし
Alan Chang
Director of Medical Affairs & Data Analyticsno dataデータなしデータなし

3.2yrs

平均在職期間

54yo

平均年齢

経験豊富な経営陣: ALLKの経営陣は 経験豊富 であると考えられます ( 3.2年の平均在職年数)。


取締役

名称ポジション在職期間報酬所有権
Robert Alexander
CEO & Director7.1yrsUS$6.30m0.77%
$ 703.6k
Paul Walker
Independent Director6.6yrsUS$387.12k0%
$ 0
Steven James
Independent Director8.2yrsUS$387.12k0%
$ 0
Neil Graham
Independent Directorless than a yearUS$378.28k0%
$ 0
Amy Ladd
Independent Director1.9yrsUS$372.12k0%
$ 0
Robert Andreatta
Independent Director6yrsUS$389.62k0%
$ 0
Bruce Bochner
Member of Scientific Advisory Boardno dataデータなしデータなし
Robert Schleimer
Member of Scientific Advisory Boardno dataデータなしデータなし
Dolca Thomas
Independent Directorless than a yearUS$732.48k0.044%
$ 39.9k

6.0yrs

平均在職期間

62yo

平均年齢

経験豊富なボード: ALLKの 取締役会経験豊富 であると考えられます ( 6年の平均在任期間)。